🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/01/2007 | 42,07 | 42,45 | 41,96 | 42,41 | +0,71% | 1,16% | 57.735 |
| 22/01/2007 | 42,56 | 42,82 | 41,92 | 42,11 | -1,32% | 2,11% | 167.246 |
| 19/01/2007 | 42,33 | 42,86 | 41,92 | 42,67 | +0,53% | 2,21% | 433.344 |
| 18/01/2007 | 42,41 | 43,23 | 42,30 | 42,45 | -0,18% | 2,21% | 403.769 |
| 17/01/2007 | 43,23 | 43,34 | 42,30 | 42,52 | -2,07% | 2,42% | 98.397 |
| 16/01/2007 | 43,46 | 44,09 | 42,67 | 43,42 | -0,60% | 3,27% | 137.537 |
| 12/01/2007 | 43,23 | 44,39 | 43,08 | 43,68 | +0,69% | 3,03% | 125.809 |
| 11/01/2007 | 42,37 | 43,53 | 42,11 | 43,38 | +2,39% | 3,36% | 133.263 |
| 10/01/2007 | 41,92 | 42,74 | 41,73 | 42,37 | +0,44% | 2,41% | 121.561 |
| 09/01/2007 | 42,22 | 42,30 | 41,73 | 42,18 | -0,27% | 1,33% | 96.314 |
| 08/01/2007 | 42,22 | 42,45 | 41,51 | 42,30 | -0,09% | 2,22% | 90.276 |
| 05/01/2007 | 41,88 | 42,48 | 41,02 | 42,33 | +1,34% | 3,49% | 523.941 |
| 04/01/2007 | 40,65 | 42,07 | 40,46 | 41,77 | +2,29% | 3,96% | 128.080 |
| 03/01/2007 | 40,69 | 40,95 | 40,27 | 40,84 | -0,37% | 1,66% | 324.233 |
| 29/12/2006 | 40,91 | 41,14 | 40,42 | 40,99 | -0,09% | 1,74% | 89.902 |
| 28/12/2006 | 41,43 | 41,85 | 40,65 | 41,02 | -1,35% | 2,89% | 209.913 |
| 27/12/2006 | 41,36 | 41,85 | 41,21 | 41,58 | +0,09% | 1,54% | 45.044 |
| 26/12/2006 | 40,99 | 41,62 | 40,80 | 41,55 | +1,28% | 2,01% | 48.624 |
| 22/12/2006 | 40,91 | 41,10 | 40,80 | 41,02 | +0,00% | 0,73% | 67.540 |
| 21/12/2006 | 41,02 | 41,25 | 40,80 | 41,02 | -0,27% | 1,09% | 104.302 |
| 20/12/2006 | 41,06 | 41,29 | 40,80 | 41,14 | -0,09% | 1,19% | 36.068 |
| 19/12/2006 | 40,84 | 41,47 | 40,80 | 41,17 | -0,45% | 1,65% | 67.059 |
| 18/12/2006 | 42,03 | 42,30 | 40,99 | 41,36 | -1,78% | 3,12% | 87.310 |
| 15/12/2006 | 42,74 | 42,82 | 41,85 | 42,11 | -1,06% | 2,28% | 184.024 |
| 14/12/2006 | 41,47 | 42,56 | 41,17 | 42,56 | +3,84% | 3,34% | 303.822 |
| 13/12/2006 | 40,24 | 40,99 | 40,05 | 40,99 | +1,77% | 2,33% | 144.270 |
| 12/12/2006 | 40,27 | 40,42 | 39,53 | 40,27 | -0,55% | 2,23% | 191.826 |
| 11/12/2006 | 40,05 | 40,84 | 39,75 | 40,50 | +0,93% | 2,71% | 227.065 |
| 08/12/2006 | 40,35 | 40,80 | 39,71 | 40,12 | +0,19% | 2,69% | 171.040 |
| 07/12/2006 | 40,69 | 41,17 | 39,71 | 40,05 | -2,01% | 3,59% | 66.765 |